Treatment patterns, resource use and costs of idiopathic pulmonary fibrosis in Spain--results of a Delphi Panel.
BMC Pulm Med
; 16: 7, 2016 Jan 12.
Article
en En
| MEDLINE
| ID: mdl-26758510
ABSTRACT
BACKGROUND:
Idiopathic pulmonary fibrosis (IPF) is a form of chronic fibrosing interstitial pneumonia characterized by progressive worsening of dyspnea and lung function, with a poor prognosis. The objective of this study was to determine treatment patterns, resource use and costs of managing Spanish patients with IPF.METHODS:
A three-round Delphi consensus panel of 15 clinical experts was held between December 2012 and June 2013 using questionnaires to describe the management of patients with IPF. A cost analysis based on Delphi panel estimates was made from the Spanish National Health System (NHS) perspective, including the direct costs of IPF diagnosis and management. Unit costs were applied to Delphi panel estimates of health resource use. Univariate sensitivity analyses were made to evaluate uncertainties in parameters.RESULTS:
The Delphi panel estimated that 20, 60 and 20% of IPF patients presented with stable disease, slow and rapid disease progression, respectively. The estimated annual cost per patient with stable disease, slow and rapid disease progression was 11,484, 20,978 and 57,759, respectively. This corresponds to a weighted average annual cost of 26,435 with itemized costs of 1,184 (4.5), 7,147 (27.0), 5,950 (22.5), 11,666 (44.1) and 488 (1.9%) for the diagnosis of IPF, treatment, monitoring, management of acute exacerbations and end-of-life care, respectively. The parameter that varied the annual cost per patient the most was resource use associated with acute exacerbations.CONCLUSIONS:
The management of patients with IPF in Spain, especially patients with rapid disease progression, has a high economic impact on the NHS.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Pautas de la Práctica en Medicina
/
Costos de la Atención en Salud
/
Fibrosis Pulmonar Idiopática
/
Recursos en Salud
Tipo de estudio:
Diagnostic_studies
/
Health_economic_evaluation
/
Prognostic_studies
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
BMC Pulm Med
Año:
2016
Tipo del documento:
Article
País de afiliación:
España